Variation of metabolites in normal human urine

[1]  Russ Greiner,et al.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.

[2]  Brian D. Sykes,et al.  Urine stability for metabolomic studies: effects of preparation and storage , 2007, Metabolomics.

[3]  Erik J. Saude,et al.  Optimization of NMR analysis of biological fluids for quantitative accuracy , 2006, Metabolomics.

[4]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[5]  Muireann Coen,et al.  Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Bennett,et al.  Fungal secondary metabolism — from biochemistry to genomics , 2005, Nature Reviews Microbiology.

[7]  T. Ratliff.  Urine markers for bladder cancer surveillance: a systematic review. , 2005, The Journal of urology.

[8]  N. Heaton,et al.  Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. , 2005, Analytical chemistry.

[9]  E Holmes,et al.  Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. , 2005, Analytical biochemistry.

[10]  Jimmy D Bell,et al.  Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. , 2005, Arthritis and rheumatism.

[11]  E Holmes,et al.  Curve-fitting method for direct quantitation of compounds in complex biological mixtures using 1H NMR: application in metabonomic toxicology studies. , 2005, Analytical chemistry.

[12]  J. Kraut,et al.  Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  T. Kwast,et al.  Urine markers for bladder cancer surveillance: a systematic review. , 2005 .

[14]  J. Lindon,et al.  NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.

[15]  W. Dunn,et al.  Measuring the metabolome: current analytical technologies. , 2005, The Analyst.

[16]  G. Reid,et al.  Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. , 2005, FEMS microbiology ecology.

[17]  Sean Ekins,et al.  Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.

[18]  M. Singer.  Metabolic failure. , 2005, Critical care medicine.

[19]  D. Häussinger,et al.  Inborn errors of biliary canalicular transport systems. , 2005, Methods in enzymology.

[20]  I. Wilson,et al.  Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. , 2004, Journal of pharmaceutical and biomedical analysis.

[21]  T. Ebbels,et al.  Evaluation of metabolic variation in normal rat strains from a statistical analysis of 1H NMR spectra of urine. , 2004, Journal of pharmaceutical and biomedical analysis.

[22]  Richard Baumgartner,et al.  Mapping high-dimensional data onto a relative distance plane - an exact method for visualizing and characterizing high-dimensional patterns , 2004, J. Biomed. Informatics.

[23]  Elaine Holmes,et al.  Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[24]  Anthony F. P. Nash,et al.  A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. , 2003, Journal of pharmaceutical and biomedical analysis.

[25]  W. Weckwerth.  Metabolomics in systems biology. , 2003, Annual review of plant biology.

[26]  U. Engelke,et al.  Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism , 2003, Annals of clinical biochemistry.

[27]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[28]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[29]  I. Wilson,et al.  Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS‐DA , 2002, FEBS letters.

[30]  T. Ebbels,et al.  Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. , 2002, Chemical research in toxicology.

[31]  P. Borer,et al.  Accurate nucleic acid concentrations by nuclear magnetic resonance. , 2002, Analytical biochemistry.

[32]  Elaine Symanski,et al.  Assessment of variability in biomonitoring data using a large database of biological measures of exposure. , 2002, AIHA journal : a journal for the science of occupational and environmental health and safety.

[33]  D Sardari,et al.  Applications of artificial neural network in AIDS research and therapy. , 2002, Current pharmaceutical design.

[34]  F. Assadi.  Quantitation of microalbuminuria using random urine samples , 2002, Pediatric Nephrology.

[35]  Elaine Holmes,et al.  Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.

[36]  E Holmes,et al.  Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. , 2001, Analytical biochemistry.

[37]  T R Brown,et al.  NMR spectral quantitation by principal component analysis , 2001, NMR in biomedicine.

[38]  A R Tate,et al.  Investigation of the metabolite variation in control rat urine using (1)H NMR spectroscopy. , 2001, Analytical biochemistry.

[39]  V. Gant,et al.  European guidelines for urinalysis: a collaborative document produced by European clinical microbiologists and clinical chemists under ECLM in collaboration with ESCMID. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[40]  Uttam Garg,et al.  Measurement of urinary concentration: a critical appraisal of methodologies , 2001, Pediatric Nephrology.

[41]  J. C. Jongste.  Surrogate markers of airway inflammation: inflammometry in paediatric respiratory medicine , 2000 .

[42]  G. Wennergren.  Inflammatory mediators in blood and urine. , 2000, Paediatric respiratory reviews.

[43]  E Holmes,et al.  Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.

[44]  J. D. de Jongste.  Surrogate markers of airway inflammation: inflammometry in paediatric respiratory medicine. , 2000, Paediatric respiratory reviews.

[45]  I. Wilson,et al.  Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[46]  C Zuppi,et al.  1H NMR spectra of normal urines: reference ranges of the major metabolites. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[47]  P. Elliott,et al.  Urinary biochemical markers of dietary intake in the INTERSALT study. , 1997, The American journal of clinical nutrition.

[48]  C Bachmann,et al.  Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. , 1994, Clinical chemistry.

[49]  A Bryan,et al.  Diabetic ketoacidosis. , 2005, American family physician.

[50]  D. Bergel.  Geigy Scientific Tables , 1991 .

[51]  K Wüthrich,et al.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.

[52]  D. Cogan.  Inborn errors. , 1961, Archives of ophthalmology.